Review
Published on 09 Jan 2025
Key considerations based on pharmacokinetic/pharmacodynamic in the design of antibody-drug conjugates
in Cancer Molecular Targets and Therapeutics
- 796 views
Review
Published on 09 Jan 2025
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 07 Jan 2025
in Cancer Molecular Targets and Therapeutics
Systematic review
Published on 07 Jan 2025
in Cancer Molecular Targets and Therapeutics
Review
Published on 07 Jan 2025
in Cancer Molecular Targets and Therapeutics
Case Report
Accepted on 06 Jan 2025
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 06 Jan 2025
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 02 Jan 2025
in Cancer Molecular Targets and Therapeutics
Review
Accepted on 30 Dec 2024
in Cancer Molecular Targets and Therapeutics
Review
Accepted on 24 Dec 2024
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 24 Dec 2024
in Cancer Molecular Targets and Therapeutics
Review
Published on 24 Dec 2024
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 24 Dec 2024
in Cancer Molecular Targets and Therapeutics
Original Research
Accepted on 06 Dec 2024
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 20 Dec 2024
in Cancer Molecular Targets and Therapeutics
Systematic Review
Published on 20 Dec 2024
in Cancer Molecular Targets and Therapeutics
Case Report
Published on 17 Dec 2024
in Cancer Molecular Targets and Therapeutics